← Back to Search

Medical Device Usage and Evaluation for Cancer

N/A

Waitlist Available

Led By Kathleen M Dungan, MD, MPH

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately following inpatient hospitalization

Awards & highlights

No Placebo-Only Group

Summary

This trial studies if using a continuous glucose monitor (CGM) can improve satisfaction and reduce stress in managing diabetes for patients with poorly controlled type 2 diabetes and active cancer. The CGM provides real-time blood sugar data to help better manage their condition. Continuous glucose monitoring (CGM) systems help patients manage their care with real-time data and have shown benefits in improving blood sugar control and quality of life.

Eligible Conditions

Cancer
Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from week 1 to week 4

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from week 1 to week 4

This trial's timeline: 3 weeks for screening, Varies for treatment, and from week 1 to week 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Diabetes Treatment Satisfaction Questionnaire (DTSQ) survey score

Secondary study objectives

Change in DTSQ scores

Change in Patient Health Questionnaire scores

Change in various measures of control

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (CGM)Experimental Treatment3 Interventions

Prior to hospital discharge, patients receive CGM application and education on how to apply the CGM, and how to use the sensor and its associated smart phone app. Patients also receive basic diabetes mellitus education. After hospital discharge, patients use CGM for up to 28 days.

Do I qualify?Apply below to find out